Secondary prophylaxis with romiplostim for temozolomide-induced thrombocytopenia in newly diagnosed glioblastoma.
Journal article

Secondary prophylaxis with romiplostim for temozolomide-induced thrombocytopenia in newly diagnosed glioblastoma.

  • Le Rhun, Emilie University of Lille, U-1192, F-59000 Lille, France; Inserm, U-1192, F-59000 Lille, France; CHU Lille, General and Stereotaxic Neurosurgery service, F-59000 Lille, France; Oscar Lambret Center, Medical Oncology Department, F-59000 Lille, Lille, France;
  • Devos, Patrick Lille University, Lille, France;
  • Houillier, Caroline Groupe Hospitalier Pitié-Salpêtrière, Paris, France;
  • Cartalat-Carel, Stéphanie Hospices Civils de Lyon, Lyon, France;
  • Chinot, Olivier L. Aix-Marseille University, AP-HM, Service de Neuro-Oncologie, CHU Timone, Marseille, France;
  • Di Stefano, Anna Luisa Groupe Hospitalier Pitié-Salpêtrière, Paris, France;
  • Dib, Malek CHU Lille, Lille, France;
  • Reyns, Nicolas University of Lille, U-1192, F-59000 Lille, France; Inserm, U-1192, F-59000 Lille, France; CHU Lille, General and Stereotaxic Neurosurgery service, F-59000 Lille, France; Oscar Lambret Center, Medical Oncology Department, F-59000 Lille, Lille, France;
  • Dubois, François University Hospital Lille, Lille, France;
  • Weller, Michael Laboratory of Molecular Neuro-Oncology, Department of Neurology, and Neuroscience Center Zurich, University Hospital and University of Zurich, Zurich, Switzerland;
Show more…
Published in:
  • Journal of Clinical Oncology. - American Society of Clinical Oncology (ASCO). - 2018, vol. 36, no. 15_suppl, p. 2042-2042
Language
  • English
Open access status
closed
Identifiers
Persistent URL
https://sonar.ch/global/documents/50564
Statistics

Document views: 53 File downloads: